Xcout Intel
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Subscribe to see Tectonic Therapeutic, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tectonic Therapeutic, Inc. at a glance
Tectonic Therapeutic, Inc. is a biotech company headquartered in Watertown, United States. It is publicly listed (TECX) with a market capitalisation of $710M. Xcout tracks 36 named people at Tectonic Therapeutic, Inc., including Alise S. Reicin (President, Chief Executive Officer, Secretary & Director).
Tectonic Therapeutic, Inc. leadership
- Alise S. ReicinPresident, Chief Executive Officer, Secretary & Director
- Alise ReicinPresident and CEO, Director
- Daniel LochnerChief Financial Officer
- Marcella K. RuddyChief Medical Officer
- Anthony MuslinChief Development Officer
- Marc SchwabishChief Business Officer
30 more named people on record for Tectonic Therapeutic, Inc., with roles, board committees and tenure — see the full roster →
Investors
Tectonic Therapeutic, Inc. competitors
A few of Tectonic Therapeutic, Inc.'s closest competitors — see the full list of competitors and alternatives →
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Alloy Therapeutics, Inc. is a biotechnology ecosystem company dedicated to democratizing access to antibodies, multispecifics, and genetic modalities, with offices in Waltham and Boston, Massachusetts.
Get Tectonic Therapeutic, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tectonic Therapeutic, Inc. in Xcout Intel
- 36 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access